Bausch and Lomb Preservision Areds 2 Eye Vitamin & Mineral Supplement / Formula - 210 Count Mini Gels

Who Uses This Product? Individuals with moderate to advanced age-related macular degeneration.

Why They Love It? Users of Bausch and Lomb AREDS 2 have reported that the supplement has slowed the progression of their age-related macular degeneration. The small soft gels are easy to swallow, and the formula doesn't contain beta-carotene, so it's safe for current and former smokers.

PreserVision AREDS 2 Eye Vitamin & Mineral Supplement is a vitamin and mineral supplement designed to help preserve eye health in people with moderate to advanced age-related macular degeneration (AMD). PreserVision is the No.1 doctor-recommended brand and the most-studied eye vitamin formula, backed by 20 years of clinical studies conducted by the National Eye Institute (NEI). The patented formula contains the exact levels of each nutrient recommended by the NEI is high in antioxidants and zinc and offers eye support that is not available in typical over-the-counter eye care supplements.

AREDS 2

In 2006, another clinical study was conducted based on new findings on AMD. During this study, the National Eye Institute wanted to improve the original formula from the AREDS study. During this time, new data had suggested an association between beta-carotene and a heightened risk of lung cancer in those with a history of smoking. This new information promoted a study on a new formula that replaced beta-carotene with lutein and zeaxanthin. 

The AREDS 2 study had 4,203 participants ranging from ages 50 to 85 years old. At the conclusion of the study, the new PreserVision AREDS 2 supplements demonstrated a reduction in the risk of progressing to advanced age-related macular degeneration. Eighteen percent of participants had a reduced risk compared to the participants that took the original AREDS formula. The NEI recommends a vitamin formula that contains the exact formulation used during the AREDS 2 study to reduce the risk of progression with AMD.  

In 1992 the National Eye Institute began to study specific nutrients that could reduce the risk of age-related macular degeneration progression. After conducting two Age-Related Eye Disease Studies (AREDS and AREDS2), the National Eye Institute recommended a specific balance of different nutrients. As a result, Bausch & Lomb created a patented formula that uses the exact levels and nutrients from the AREDS2 Study. This updated formula replaces beta-carotene with lutein and zeaxanthin so that it's OK for current and former smokers. This new formula is recommended by doctors everywhere.